Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-05Clinical Trial Update: Impact in Off-spring of Mothers After Perinatal Daily Intake of a Probiotic [NA]
A completed clinical trial investigated whether daily perinatal intake of a probiotic by mothers affects offspring outcomes related to asthm…
-
FDA approval · 2016-01-26FDA Approved: ALLERGY RELIEF — Supplemental Application (Prodose, Inc)
The FDA approved a supplemental application for Allergy Relief containing cetirizine hydrochloride from Prodose, Inc, under ANDA077829.
-
FDA approval · 2016-01-26FDA Approved: FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Fexofenadine HCl and Pseudoephedrine HCl (Dr. Reddy's Laboratories Limited). This approval invol…
-
FDA approval · 2016-01-11FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for levocetirizine dihydrochloride from Macleods Pharmaceuticals Limited as a generic antihistamine.
-
CLINICAL_TRIALS trial_result · 2016-01-07Clinical Trial Update: Efficacy Study in Allergic Rhinitis Patients After Intranasal Administration of AZD8848 [Phase 2]
Phase 2 efficacy trial update for intranasal AZD8848 in allergic rhinitis. The study is completed and results were posted in January 2016.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-01-04FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approves a supplemental application for Montelukast Sodium from Torrent Pharmaceuticals Limited under ANDA 201515.
-
FDA approval · 2015-12-30FDA Approved: CLARITIN ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application for CLARITIN ALLERGY (loratadine) from Bayer HealthCare LLC.
-
CLINICAL_TRIALS trial_result · 2015-12-29Clinical Trial Update: Intraseasonal Short-time Up-dosing With Alutard SQ Grasses [Phase 3]
A Phase 3 trial evaluating intraseasonal short-time up-dosing with Alutard SQ Grasses for grass pollen allergy has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-24Clinical Trial Update: Study to Assess the Effects of Allergic Rhinitis and Co-administration of Mometasone or Oxymetazoline on the Pharmacokinetics, Safety, and Tolerability of Intranasal Esketamine [Phase 1]
A Phase 1 study evaluated whether co-administration of mometasone or oxymetazoline with intranasal esketamine affects pharmacokinetics, safe…
-
FDA approval · 2015-12-23FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application to add Claritin chewable grape and bubblegum formulations containing loratadine from Bayer Healt…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Evaluation of Efficacy of Dellegra in Exposure Unit [Phase 4]
The Phase 4 study evaluating Dellegra for allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis [Phase 3]
A Phase 3 confirmatory trial of TAU-284 in pediatric patients with perennial allergic rhinitis has completed and posted results.
-
FDA approval · 2015-12-10FDA Approved: CLARITIN ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin Allergy (loratadine) by Bayer HealthCare LLC., under NDA020641. This action represents …
-
FDA approval · 2015-12-09FDA Approved: CLARITIN LIQUI-GELS — Supplemental Application (Bayer HealthCare LLC.)
This FDA entry records a supplemental application for Claritin Liqui-Gels (loratadine) submitted by Bayer HealthCare LLC. The submission sta…
-
FDA approval · 2015-12-08FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Montelukast sodium from Rising Pharma Holdings, Inc. under an ANDA, marking approval of a supple…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy [Phase 2]
A Phase 2 randomized trial evaluating a novel method of specific allergen immunotherapy for grass pollen-induced rhinoconjunctivitis has com…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in EEC [Phase 2]
Phase 2 study by Anergis comparing dose regimens of AllerT in adults with birch pollen–induced allergic rhino-conjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis
A pilot clinical trial evaluated a cutaneous antigen neutralization test in patients with rhinoconjunctivitis; the study has completed.
-
CLINICAL_TRIALS research · 2015-12-03Clinical Trial Update: AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR) [Phase 4]
A Phase 4 clinical trial update evaluating azelastine/fluticasone nasal spray for symptom control, nasal mediators, and nasal hyperresponsiv…
-
CLINICAL_TRIALS other · 2015-12-03Clinical Trial Update: Role of the Central Nervous System in Allergic Rhinitis [NA]
A clinical trial investigating the role of the central nervous system in allergic rhinitis triggered by house dust mite allergy has been ter…
-
FDA approval · 2015-12-02FDA Approved: CARBINOXAMINE MALEATE EXTENDED-RELEASE ORAL SUSPENSION — Supplemental Application (Neos Therapeutics, LP)
FDA approved a supplemental application for an extended-release oral suspension form of carbinoxamine maleate, adding a new dosage form to t…
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Evaluation of High Speed Laser Doppler Imaging Technology [NA]
The update notes the completion of a clinical trial evaluating high-speed laser Doppler imaging technology for allergic rhinitis (hay fever)…
-
FDA approval · 2015-11-30FDA Approved: BUDESONIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Budesonide from Chartwell RX, LLC, authorizing a change to an existing generic product.
-
CLINICAL_TRIALS trial_result · 2015-11-30Clinical Trial Update: A Study Assessing the Safety and Effectiveness of FEX60/PE10 Fixed Combination Tablet in Patients With Allergic Rhinitis [Phase 3]
A Phase 3 trial evaluating the safety and effectiveness of FEX60/PE10 fixed-dose combination tablet in allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies [Phase 1]
Phase 1 sublingual immunotherapy trials for grass and dust mite allergies conducted by Stanford University have completed. The studies focus…